Literature DB >> 21204611

Insights into 'fermentonomics': evaluation of volatile organic compounds (VOCs) in human disease using an electronic 'e-nose'.

R P Arasaradnam1, N Quraishi, I Kyrou, C U Nwokolo, M Joseph, S Kumar, K D Bardhan, J A Covington.   

Abstract

Detection of volatile organic compounds (VOCs) is a common requirement in industry for which numerous methods are available. The electronic nose (e-nose) is an example. Rather than individual chemicals, the e-nose recognizes the 'aroma fingerprint' created by the collection of VOCs in samples, comparable to the human nose. We report on a novel application for gastrointestinal and metabolic medicine, and compare its results to mass spectrometry. Fermentation of undigested foods in the large bowel by its resident bacteria results in the creation of several chemicals including volatile gases that influence colonic and metabolic health. Using urine samples, preliminary results indicate the ability of the e-nose to distinguish between controls and those with inflammatory bowel disease or diabetes (separation rate of ∼97%). This emphasizes the different patterns of fermentation. Our term 'fermentonomics' describes the investigation and analysis of the fermentome by such non-invasive means. Such an approach has potentially wide application in medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21204611     DOI: 10.3109/03091902.2010.539770

Source DB:  PubMed          Journal:  J Med Eng Technol        ISSN: 0309-1902


  8 in total

1.  The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients.

Authors:  S F Shepherd; N D McGuire; B P J de Lacy Costello; R J Ewen; D H Jayasena; K Vaughan; I Ahmed; C S Probert; N M Ratcliffe
Journal:  J Breath Res       Date:  2014-03-27       Impact factor: 3.262

2.  Flatography: Detection of gastrointestinal diseases by faecal gas analysis.

Authors:  Evelien F de Groot; Tim G de Meij; Daniel J Berkhout; Marc P van der Schee; Nanne K de Boer
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

3.  Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer.

Authors:  Peter J Mazzone; Xiao-Feng Wang; Sung Lim; Humberto Choi; James Jett; Anil Vachani; Qi Zhang; Mary Beukemann; Meredith Seeley; Ray Martino; Paul Rhodes
Journal:  BMC Cancer       Date:  2015-12-23       Impact factor: 4.430

4.  Application of a novel tool for diagnosing bile acid diarrhoea.

Authors:  James A Covington; Eric W Westenbrink; Nathalie Ouaret; Ruth Harbord; Catherine Bailey; Nicola O'Connell; James Cullis; Nigel Williams; Chuka U Nwokolo; Karna D Bardhan; Ramesh P Arasaradnam
Journal:  Sensors (Basel)       Date:  2013-09-06       Impact factor: 3.576

5.  Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis--a pilot study.

Authors:  Ramesh P Arasaradnam; Eric Westenbrink; Michael J McFarlane; Ruth Harbord; Samantha Chambers; Nicola O'Connell; Catherine Bailey; Chuka U Nwokolo; Karna D Bardhan; Richard Savage; James A Covington
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

6.  Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.

Authors:  Ramesh P Arasaradnam; Michael J McFarlane; Courtenay Ryan-Fisher; Erik Westenbrink; Phoebe Hodges; Paula Hodges; Matthew G Thomas; Samantha Chambers; Nicola O'Connell; Catherine Bailey; Christopher Harmston; Chuka U Nwokolo; Karna D Bardhan; James A Covington
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

7.  Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.

Authors:  Enzo Vicari; Michele Salemi; Giuseppe Sidoti; Mariano Malaguarnera; Roberto Castiglione
Journal:  Nutrients       Date:  2017-11-03       Impact factor: 5.717

8.  The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: a pilot study.

Authors:  James A Covington; Linda Wedlake; Jervoise Andreyev; Nathalie Ouaret; Matthew G Thomas; Chuka U Nwokolo; Karna D Bardhan; Ramesh P Arasaradnam
Journal:  Sensors (Basel)       Date:  2012-09-26       Impact factor: 3.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.